deepc funding news – Munich-based deepc Secures €12 Million in Series A Extension Round Funding

Along with participation from new investors KHP Ventures and SwissHealth Ventures as well as returning partner Winning Mindset Ventures, the funding was co-led by Sofinnova Partners and Bertelsmann Investments.

Read also - Payflow funding news – Barcelona-based Payflow Secures €6 Million in Funding

The money will be used to further develop and market deepc's market-leading operating system, as well as to expedite the company's growth and global expansion. It's expansion in the US, its continued growth in the UK, and its concentration on important European markets are among its top growth targets.

Leading institutions now use it's platform, including the National Health Service (NHS) in England, the Vivantes Hospital Group and LMU University Hospital in Germany, CHU Brugmann (Brugmann University Hospital) in Belgium, and Solothurn Hospital in Switzerland.

Dr. Franz Pfister, CEO and Co-Founder of deepc, said: “At deepc, we believe that the potential for AI in healthcare will only be realized if we can bridge the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to adopt the best AI technologies at pace and at scale, enabling faster, more accurate diagnoses and ultimately improving patient outcomes. We are thrilled to welcome SwissHealth Ventures and KHP Ventures, alongside our existing investors Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures. Together, they bring tremendous strategic value to deepc and will be a major asset as we continue to scale internationally and invest further in our platform.”

The rapid advancements in radiology AI can now be accessed by clinicians through deepcOS®, which gives them access to regulatory-approved AI solutions for over 60 clinical indications. This eliminates any technological, operational, or financial complication and lets healthcare providers take advantage of these advancements. It is also contributing to the acceleration of the creation of new AI solutions by providing low-barrier access to its extensive client base and distribution network, which spans more than 30 countries.

Simon Turner, Partner at Sofinnova Partners, added: “The influx of capital into AI is highlighting the importance of enabling technologies that drive adoption in healthcare. These enabling technologies are the focus of the Sofinnova Digital Medicine strategy, and an area that few have yet to command. From the outset, we recognized deepc’s potential to revolutionize AI deployment in healthcare. This conviction is reinforced today by the support of our new investors who bring a wealth of expertise to further accelerate the company’s growth.”

About Deepc

Deepc, which was established in 2019, is committed to ensuring that all patients receive accurate and secure diagnostics. The company has a proven track record of assisting radiology AI suppliers in deploying their technologies in clinical settings by providing a single integration solution.

In the field of radiology AI, deepc is a trailblazing startup that has the potential to significantly democratise health access. Their product, deepcOS®, an unparalleled cloud-native Radiology AI platform, is at the centre of their purpose. Offering a vendor-neutral strategy, deepcOS® has a vast library of state-of-the-art AI applications.